Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3013353 Title: INHIBITEURS PEPTIDIQUES PERMÉABLES AUX CELLULES DE LA VOIE DE TRANSDUCTION DU SIGNAL JNK POUR LE TRAITEMENT DE DE LA CYSTITE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
147340038
WO application number:
EP2014001736
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3013353
WO publication number:
WO2014206563
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
26/06/2014
Grant date:
21/04/2021
EP publication date:
04/05/2016
WO publication date:
31/12/2014
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
21/04/2021
EP B1 publication date:
21/04/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/06/2024
Expiration date (if granted and all annual fees paid):
26/06/2034

Applicant

Name:
Xigen Inflammation Ltd.
Legal Form:
From:
21/04/2021
Address:
Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)
To:

Agent

Name:
Weickmann & Weickmann Patentanwalte-Rechtsanwalt PartmbB
Legal Form:
From:
21/04/2021
Address:
Postfach 860 820, 81635, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
COMBETTE, Jean-Marc
Legal Form:
Address:
74140 Saint Cergues, France (FR)

2

Name:
DELOCHE, Catherine
Legal Form:
Address:
CH-1207 Genf, Switzerland (CH)

Priority

1

Priority patent number:
PCT/EP2013/001896
Priority date:
27/06/2013
Priority country:
World Intellectual Property Office (WIPO) (WO)

2

Priority patent number:
PCT/EP2013/001881
Priority date:
26/06/2013
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 38/17; A61K 38/55; A61K 48/00; A61P 1/00; A61P 1/02; A61P 1/04; A61P 1/16; A61P 1/18; A61P 3/00; A61P 3/08; A61P 3/10; A61P 5/00; A61P 13/12; A61P 25/28; A61P 41/00; C07K 14/47; C07K 16/40; C12N 15/00;

Publication

European Patent Bulletin

Issue number:
202116
Publication date:
21/04/2021
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
20/06/2023
Last annual fee paid number:
10
Last annual fee paid amount:
185 Euro
Payer:
DENNEMEYER & Co S.A.R.L.
Filing date Document type Publication Type Document Description Number of pages File Type
20/04/2021 Power Of Attorney Power of attorney 5 PDF /6/7/7/3/1/0722113776/docs/147340038_0_powerofattorneyspecific_20210421_121808402.pdf